ERGOMED

Co-Development and Products

Benefit to Pharma & Biotech Companies

Through its association with many healthcare companies over several years ERGOMED has gained considerable understanding of the specific needs of the sector.

Through working with many healthcare companies over 15 years, Ergomed has gained considerable understanding of effective and cost efficient development strategies. Ergomed has shaped its clinical development and supporting organisation to help to meet the specific needs of biotech and specialist companies. For example this is carried out through the provision of regulatory services for specialty products/ orphan drugs, enhanced patient recruitment using Site Management teams and study site co-ordinators, safety database and drug safety monitoring and special quality assurance and audit services.

By sharing the risk and expense of development with the sponsor company, this model has been used effectively to enable drugs to be developed more quickly and efficiently to proof of concept.

whiteslide23

Translate »